ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2018 American Transplant Congress

    10-Year Outcomes of Renal Transplantation from Circulatory Death Donors with Increased Terminal Creatinine

    Y. Tomita, K. Iwadoh, I. Nakajima, S. Fuchinoue.

    Surgery III, Tokyo Women's Medical University, Tokyo, Japan.

    Background: To alleviate chronic renal graft shortages in Japan, donation after circulatory death (DCD) is an increasingly used organ resource. Organs from DCD donors with…
  • 2018 American Transplant Congress

    TLR-Activated Bregs Promote Islet Allograft Tolerance in an IL-10-Independent and TGF-β-Dependent Manner

    L. Kojima, K. Lee, K. Deng, H. Tector, C. Dai, S. Kimura, C. Rickert, H. Yeh, J. Markmann.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.

    Background: We previously demonstrated the potent capacity of regulatory B cells (Bregs) to mitigate allograft immunity. Recently, we produced TLR-activated B cells in vitro that…
  • 2018 American Transplant Congress

    Complement Activating HLA Class 2 Antibodies Are Associated with Poor Renal Allograft Survival; Multicentre Study

    A. Babu,1,2 O. Shaw,5 N. Khovanova,2 S. Griffin,4 D. Briggs,6 N. Krishnan,1 S. Fletcher,1 C. Imray,1 A. Seitz,3 R. Baker,3 M. Wellberry-Smith,3 B. Clarke,3 K. Cullen,3 F. Edwards,4 T. Rees,4 E. Burrows,4 L. Howe,5 R. Vaughan,5 N. Kessaris,7 N. Mamode,7 A. Dorling,7 D. Zehnder,1 R. Higgins,1,2 D. Mitchell,2 S. Daga.2,3

    1Renal Transplantation, University Hospitals Coventry, Coventry, United Kingdom; 2University of Warwick, Coventry, United Kingdom; 3Renal Transplantation, St James University Hospital, Leeds, United Kingdom; 4Renal Transplantation, University Hospital of Wales, Cardiff, United Kingdom; 5H&I, Viapath,, London, United Kingdom; 6H&I, NHSBT, Birmingham, United Kingdom; 7Renal Transplantation, Guys and St Thomas Hospital, London, United Kingdom.

    IntroductionRole of Class I and II pre-formed complement activating antibodies on renal outcomes is not well defined. In this multicentre study, we looked at the…
  • 2017 American Transplant Congress

    Anti-Angiotensin Type 1 Receptor Antibodies Associate with Rejection in Simultaneous Pancreas and Kidney Transplant and Pancreas Transplant Alone Recipients.

    A. Peng, D. Dafoe, J. Choi, A. Vo, X. Zhang, R. Najjar, E. Huang, S. Jordan.

    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA

    Background: Anti-angiotensin type 1 receptor antibodies (AT1R Ab) have been found to have a strong association with antibody mediated rejection (Reinsmoen et al, Transpl 2010;…
  • 2017 American Transplant Congress

    Impact of Type of Recipient Diabetes on 1 and 3-Year Kidney Allograft and Patient Outcomes.

    S. Kim, F. Wu, D. Cibrik, Y. Li, A. Naik.

    University of Michigan, Ann Arbor

    The pathophysiology of type 1 (T1DM) and type 2 (T2DM) diabetes is different and has been conjectured to impact transplantation outcomes differently over time especially…
  • 2017 American Transplant Congress

    Results of Biliary Reconstruction with PTFE Graft in Liver Transplantation.

    E. Ayvazoglu Soy,1 G. Moray,1 A. Torgay,2 H. Ozdemir,3 M. Haberal.1

    1General Surgery and Transplantation, Baskent University, Ankara, Turkey; 2Anesthesiology, Baskent University, Ankara, Turkey; 3Pathology, Baskent University, Ankara, Turkey

    Introduction: Biliary complications are often referred to as the 'Achilles heel' of liver transplantation (LT) with their high incidence rate, the need for repeated and…
  • 2017 American Transplant Congress

    Inflammasome, Unfolded Protein Response, and T Cell Immunity in DAIH.

    A. Arterbery,1 M. Martinez,3 S. Lobritto,3 Y. Avitzur,2 U. Ekong.1

    1Ped Gastro. and Hep., Yale University, New Haven, CT; 2Gastro., Hep., and Nutr., Hospital for Sick Children, Toronto, ON, Canada; 3Ped. Gastro., Hep., and Nutr., Columbia University, New York, NY

    Background: Regulatory T cells (Tregs) of patients with de novo autoimmune hepatitis (DAIH) secrete IL-17A & IFN-g; display TH1 & TH17 pehnotypes & are functionally…
  • 2017 American Transplant Congress

    Short- and Long-Term Graft Survival After Kidney Transplantation in Western Europe.

    M. Coemans,1 G. Verbeke, D. Anglicheau, O. Bestard, M. Giral, M. Naesens.1,2

    1Microbiology and Immunology, KU Leuven, Leuven, Belgium; 2Nephrology and Renal Transplantation, KU Leuven, Leuven, Belgium

    Background: Improvement of kidney survival after transplantation has mainly been studied in the American population. There, it was found that improvement mostly occurred on the…
  • 2017 American Transplant Congress

    Deleting LAG-3 Accelerates Cardiac Allograft Rejection and Augments T Cell Memory in Mice.

    J. Erfe,1,2 C. Yang,1 D. Ndishabandi,1 I. Rosales,1 R. White,1 P. Russell,1 R. Colvin,1 J. Madsen,1 A. Alessandrini.1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA; 2Yale School of Medicine, New Haven, CT

    Purpose: Lymphocyte Activation Gene-3 (LAG-3) expresses a transmembrane receptor on activated immune cells such as T cells, NK cells, and plasmacytoid dendritic cells. It is…
  • 2017 American Transplant Congress

    Renal Transplant Outcomes in Primary FSGS Compared with Other Recipients: A National Review of the Irish Transplant Registry.

    S. Cormican,1 C. Kennedy,1,2 P. O'Kelly,1 B. Doyle,3 A. Dorman,3 P. Conlon.1,2

    1Nephrology, Beaumont Hospital, Dublin, Ireland; 2Medicine, Royal College of Surgeons, Dublin, Ireland; 3Pathology, Beaumont Hospital, Dublin, Ireland

    Primary focal segmental glomerular sclerosis (p-FSGS) raises specific peri-transplant concerns, one of which is disease recurrence (r-FSGS). We aimed to compare transplant outcomes in patients…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences